Eliquis receives EU approval
Bristol-Myers Squibb Company and Pfizer Inc. have announced that the European Commission has approved Eliquis for the treatment of deep vein thrombosis and pulmonary embolism, and the prevention of recurrent DVT and PE in adults.
Source: Pharmacy Europe - Category: Drugs & Pharmacology Authors: AMcculloch Tags: *** Editor's Pick Anti-coagulants Haematology Bristol-Myers Squibb Company dvt Eliquis EU approval Latest News pe Pfizer Inc. Source Type: news